The Health Innovation Roundup, sponsored by Health Cities, is written and published weekly by Taproot Edmonton to bring you the latest news and events in research, technology, companies and people changing health for the better in Edmonton.

Sign up to get the full edition delivered directly to your inbox. Use the code HEALTHCITY & you’ll get 10% off the first year.

Here are some highlights from this week’s Health Innovation Roundup:


        • MIC Medical Imaging (MIC), which offers radiology services throughout Alberta, has partnered with Voyce Canada to provide remote, on-demand access to trained and certified interpreters, so patients can interact with staff in more than 240 languages, including American Sign Language. The companies were connected through Health Cities. “Not only are we introducing a new company to Alberta’s health innovation market, this project addresses challenges facing care providers and increases equity and access to care,” said CEO Reg Joseph in a release.
        • Medical engineering company MACH32 gave Global News a look at its autoinjector to quickly deliver medications that stop hemorrhaging, as well as its anti-aerosol tent.
        • Thanks to a grant from Alberta Innovates, a team of researchers at the University of Alberta will continue to develop a dental ultrasound system to better detect dental disease. “Having a 2D image is like being in the forest with no bearings and no idea what’s going on in the neighbourhood,” principal investigator Lawrence Le told Folio. “By transforming 2D images into 3D images, we will be able to really look around at different angles, giving a view of the soft tissue, blood flow and bone.”
        • Microbiology and immunology professor David Evans and public health expert Timothy Caulfield of the University of Alberta told Postmedia what Albertans need to know about monkeypox.
        • Dr. Calvin Howard, who came by a love for neuroscience in high school in Fort Saskatchewan, spoke about his research into using diagnosing dementia more quickly with the help of artificial intelligence, which he’ll be pursuing in Boston.
        • Evusheld, a new drug shown to help prevent COVID-19 infections in immunocompromised people, is now available in Alberta. It is not a treatment but rather a long-acting antibody for those for whom a vaccine is not enough protection.


Have a suggestion for a future edition? Send it to for consideration.

Become a “Roundup Cultivator” and sponsor Taproot Edmonton to help them chronicle health innovation in Edmonton. Learn more